tiprankstipranks
Trending News
More News >
Kits Eyecare (TSE:KITS)
TSX:KITS
Canadian Market

Kits Eyecare (KITS) Stock Forecast & Price Target

Compare
69 Followers
See the Price Targets and Ratings of:

KITS Analyst Ratings

Strong Buy
4Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Kits
Eyecare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

KITS Stock 12 Month Forecast

Average Price Target

C$16.63
▲(19.81%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Kits Eyecare in the last 3 months. The average price target is C$16.63 with a high forecast of C$18.00 and a low forecast of C$14.50. The average price target represents a 19.81% change from the last price of C$13.88.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"C$4","19":"C$19","7.75":"C$7.75","11.5":"C$11.5","15.25":"C$15.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$18.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$16.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$14.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,7.75,11.5,15.25,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,11.667692307692308,12.195384615384615,12.723076923076924,13.250769230769231,13.778461538461539,14.306153846153848,14.833846153846155,15.361538461538462,15.88923076923077,16.416923076923077,16.944615384615386,17.472307692307695,{"y":18,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,11.562307692307693,11.984615384615385,12.406923076923077,12.829230769230769,13.25153846153846,13.673846153846153,14.096153846153847,14.518461538461537,14.94076923076923,15.363076923076921,15.785384615384615,16.207692307692305,{"y":16.63,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,11.14,11.39846153846154,11.656923076923077,11.915384615384616,12.173846153846155,12.432307692307692,12.69076923076923,12.94923076923077,13.207692307692309,13.466153846153846,13.724615384615385,13.983076923076922,14.241538461538461,{"y":14.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":6.02,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.66,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.26,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.96,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.68,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.59,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.97,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.18,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.96,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.43,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.84,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.14,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetC$18.00Average Price TargetC$16.63Lowest Price TargetC$14.50
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TSE:KITS
TipRanks AITipRanks
Not Ranked
TipRanks
C$16.5
Buy
18.88%
Upside
Reiterated
06/05/25
Kits Eyecare's overall stock score of 77 reflects its strong financial performance and positive earnings outlook, driven by impressive revenue growth and strategic investments. The technical indicators support a short-term bullish trend, although the high P/E ratio suggests caution due to high valuation. Corporate events further bolster confidence in the company's future growth prospects.
Stifel Nicolaus Analyst forecast on TSE:KITS
Martin LandryStifel Nicolaus
Stifel Nicolaus
C$18
Buy
29.68%
Upside
Reiterated
05/08/25
Stifel Nicolaus Sticks to Its Buy Rating for Kits Eyecare (KITS)
Haywood
C$18
Buy
29.68%
Upside
Reiterated
05/07/25
KITS reported Q1/25 revenue/Adj. EBITDA of $46.6M/$3.5M, in line with its preannouncement and versus our $47.0M/$3.3M estimates, and consensus of $46.9M/$3.1M. Gross margin was 36.7% vs our 36% estimate and organic growth continues to impress at 34% - this is the 3rd consecutive quarter of 30%+ organic revenue growth. EBITDA margin benefitted in the quarter from a robust number of repeat customers – 62% of rev in the quarter came from repeat customers. Management guided Q2/25 revenue between $48-50M, a positive surprise, along with 3-5% Adj. EBITDA margin, marginally below where street consensus is – midpoint of EBITDA margin guidance suggests a 50 bps YoY expansion. We attribute the Q2 EBITDA margin guide coming in light versus street expectations of 5% margin due to near-term planned marketing investments attributed to its Own this Town playbook.
Canaccord Genuity Analyst forecast on TSE:KITS
Luke HannanCanaccord Genuity
Canaccord Genuity
C$14.5
Buy
4.47%
Upside
Reiterated
03/26/25
Canaccord Genuity Reiterates Buy Rating on KITS Eyecare Ltd (KITS:CN)Canaccord Genuity analyst Luke Hannan reiterated a Buy rating and Cdn$14.50 price target on KITS Eyecare Ltd (KITS:CN).
Roth MKM Analyst forecast on TSE:KITS
Matt KorandaRoth MKM
Roth MKM
C$16
Buy
15.27%
Upside
Reiterated
03/20/25
Roth MKM Reaffirms Their Buy Rating on Kits Eyecare (KITS)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on TSE:KITS
TipRanks AITipRanks
Not Ranked
TipRanks
C$16.5
Buy
18.88%
Upside
Reiterated
06/05/25
Kits Eyecare's overall stock score of 77 reflects its strong financial performance and positive earnings outlook, driven by impressive revenue growth and strategic investments. The technical indicators support a short-term bullish trend, although the high P/E ratio suggests caution due to high valuation. Corporate events further bolster confidence in the company's future growth prospects.
Stifel Nicolaus Analyst forecast on TSE:KITS
Martin LandryStifel Nicolaus
Stifel Nicolaus
C$18
Buy
29.68%
Upside
Reiterated
05/08/25
Stifel Nicolaus Sticks to Its Buy Rating for Kits Eyecare (KITS)
Haywood
C$18
Buy
29.68%
Upside
Reiterated
05/07/25
KITS reported Q1/25 revenue/Adj. EBITDA of $46.6M/$3.5M, in line with its preannouncement and versus our $47.0M/$3.3M estimates, and consensus of $46.9M/$3.1M. Gross margin was 36.7% vs our 36% estimate and organic growth continues to impress at 34% - this is the 3rd consecutive quarter of 30%+ organic revenue growth. EBITDA margin benefitted in the quarter from a robust number of repeat customers – 62% of rev in the quarter came from repeat customers. Management guided Q2/25 revenue between $48-50M, a positive surprise, along with 3-5% Adj. EBITDA margin, marginally below where street consensus is – midpoint of EBITDA margin guidance suggests a 50 bps YoY expansion. We attribute the Q2 EBITDA margin guide coming in light versus street expectations of 5% margin due to near-term planned marketing investments attributed to its Own this Town playbook.
Canaccord Genuity Analyst forecast on TSE:KITS
Luke HannanCanaccord Genuity
Canaccord Genuity
C$14.5
Buy
4.47%
Upside
Reiterated
03/26/25
Canaccord Genuity Reiterates Buy Rating on KITS Eyecare Ltd (KITS:CN)Canaccord Genuity analyst Luke Hannan reiterated a Buy rating and Cdn$14.50 price target on KITS Eyecare Ltd (KITS:CN).
Roth MKM Analyst forecast on TSE:KITS
Matt KorandaRoth MKM
Roth MKM
C$16
Buy
15.27%
Upside
Reiterated
03/20/25
Roth MKM Reaffirms Their Buy Rating on Kits Eyecare (KITS)
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kits Eyecare

1 Month
xxx
Success Rate
7/10 ratings generated profit
70%
Average Return
+1.83%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +1.83% per trade.
3 Months
xxx
Success Rate
9/11 ratings generated profit
82%
Average Return
+20.15%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +20.15% per trade.
1 Year
Martin LandryStifel Nicolaus
Success Rate
10/10 ratings generated profit
100%
Average Return
+49.69%
reiterated a buy rating last month
Copying Martin Landry's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +49.69% per trade.
2 Years
xxx
Success Rate
11/11 ratings generated profit
100%
Average Return
+80.88%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +80.88% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KITS Analyst Recommendation Trends

Rating
Oct 24
Nov 24
Jan 25
Mar 25
May 25
Strong Buy
1
4
7
11
10
Buy
8
5
2
4
4
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
9
9
15
14
In the current month, KITS has received 14 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KITS average Analyst price target in the past 3 months is 16.63.
Each month's total comprises the sum of three months' worth of ratings.

KITS Financial Forecast

KITS Earnings Forecast

Next quarter’s earnings estimate for KITS is C$0.03 with a range of C$0.01 to C$0.04. The previous quarter’s EPS was C$0.05. KITS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.37% of the time in the same period. In the last calendar year KITS has Outperformed its overall industry.
Next quarter’s earnings estimate for KITS is C$0.03 with a range of C$0.01 to C$0.04. The previous quarter’s EPS was C$0.05. KITS beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.37% of the time in the same period. In the last calendar year KITS has Outperformed its overall industry.

KITS Sales Forecast

Next quarter’s sales forecast for KITS is C$49.01M with a range of C$48.80M to C$49.33M. The previous quarter’s sales results were C$46.59M. KITS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 55.61% of the time in the same period. In the last calendar year KITS has Outperformed its overall industry.
Next quarter’s sales forecast for KITS is C$49.01M with a range of C$48.80M to C$49.33M. The previous quarter’s sales results were C$46.59M. KITS beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 55.61% of the time in the same period. In the last calendar year KITS has Outperformed its overall industry.

KITS Stock Forecast FAQ

What is TSE:KITS’s average 12-month price target, according to analysts?
Based on analyst ratings, Kits Eyecare’s 12-month average price target is 16.63.
    What is TSE:KITS’s upside potential, based on the analysts’ average price target?
    Kits Eyecare has 19.81% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TSE:KITS a Buy, Sell or Hold?
          Kits Eyecare has a consensus rating of Strong Buy which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Kits Eyecare’s price target?
            The average price target for Kits Eyecare is 16.63. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is C$18.00 ,the lowest forecast is C$14.50. The average price target represents 19.81% Increase from the current price of C$13.88.
              What do analysts say about Kits Eyecare?
              Kits Eyecare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of TSE:KITS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis